Patents Assigned to Kalypsys
  • Patent number: 8080563
    Abstract: The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: December 20, 2011
    Assignee: Kalypsys
    Inventors: Steven P. Govek, Andrew K. Shiau, Stewart A. Noble, David J. Thomas